Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Genitourinary 1

Conditions

Sarcoma 2Oligodendroglioma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Kidney Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Dendritic Cell Sarcoma, Interdigitating 1Chordoma 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Filgrastim 10Ifosfamide 6Carboplatin 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Doxorubicin 4Cyclophosphamide 4pembrolizumab 3Thiotepa 3Temozolomide 3Etoposide 3Busulfan 3sargramostim 2ixabepilone 2fludarabine phosphate 2etoposide phosphate 2belinostat 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2Mycophenolic Acid 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Bortezomib 2Antilymphocyte Serum 2Amifostine 2tremelimumab 1seribantumab 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Panobinostat × Sarcoma × Clear all
NCT01005797 2017-03-03

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Medical University of South Carolina

Phase 1 Completed
38 enrolled
GenitourinarySarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡